首页> 外文期刊>Advances in Infectious Diseases >Essential Gene(s) Targeted by Peptide Nucleic Acids Kills &i&Mycobacterium smegmatis&/i& in Culture and in Infected Macrophages
【24h】

Essential Gene(s) Targeted by Peptide Nucleic Acids Kills &i&Mycobacterium smegmatis&/i& in Culture and in Infected Macrophages

机译:肽核酸靶向的必需基因杀死& i& mycobacterium smogmatis& / i& 在培养和感染的巨噬细胞

获取原文
       

摘要

Background: Antisense peptide nucleic acids (PNAs) exhibit growth inhibitory effects on bacteria by inhibiting the expression of essential genes and could be promising therapeutic agents for treating bacterial infections. A study was carried out to determine the efficacy of several antisense PNAs in inhibiting extracellular and intracellular growth of Mycobacterium smegmatis . Methods: Six PNAs obtained from a commercial supplier were tested to evaluate the inhibitory effect on bacterial growth by inhibiting the expression of the following essential genes: inhA (a fatty acid elongase), rpsL (ribosomal S12 protein), gyrA (DNA gyrase), pncA (pyrazinamidase), polA (DNA polymerase I) and rpoC (RNA polymerase β subunit) of M. smegmatis . Each PNA was tested at 20 μM, 10 μM, 5 μM and 2.5 μM concentrations to determine whether they caused a dose dependent killing of M. smegmatis cultured in Middlebrook 7H9 broth or in a J774A.1 murine macrophage cell line. Results: In Middlebrook broth, the strong growth inhibitory effect against M. smegmatis was observed by PNAs targeting the inhA and rpsL genes at all four concentrations. The PNAs targeting the pncA , polA and rpoC genes were found to exhibit strong growth inhibition against M. smegmatis but only at 20 μM concentration. No growth inhibition of M. smegmatis was seen in pure culture when treated with PNAs targeting gyrA and a mismatch PNA targeting dnaG (DNA primase). All six PNAs showed killing of M. smegmatis in J774A.1 macrophage cell line that were statistically significant (p < 0.05). Conclusion: It may be concluded from this study that PNAs could be potential therapeutics for mycobacterial infections.
机译:背景:反义肽核酸(PNA)通过抑制必需基因的表达而表现出对细菌的生长抑制作用,并且可能是用于治疗细菌感染的治疗剂。进行了一种研究以确定几种反义PNA抑制侦察分枝杆菌细胞外和细胞内生长的疗效。方法:通过抑制以下必需基因的表达,测试从商业供应商获得的六个PNA,以评估细菌生长的抑制作用:ONHA(脂肪酸连续酶),RPS1(核糖体S12蛋白),GYRA(DNA乙酶), PNCA(吡嗪酰胺酶),POLA(DNA聚合酶I)和M.Smogmatis的RPOC(RNA聚合酶β亚基)。每个PNA在20μm,10μm,5μm和2.5μm浓度下测试,以确定它们是否导致在中间肉汤中培养的M. Smogmatis的剂量依赖性杀死。结果:在中间体肉汤中,PNA在所有四种浓度下靶向INHA和RPSL基因的PNA和RPSL基因的强生长抑制作用。发现靶向PNCA,POLA和RPOC基因的PNA对M. SMEGMATIS表现出强烈的生长抑制,但仅以20μM浓度为20μM。当用靶向Gyra和靶向DNAG(DNA Primase)的错配PNA处理PNA处理时,在纯培养中没有看到M. Smogmatis的生长抑制。所有六种PNA都显示出在J774A.1巨噬细胞系中杀害M. Smogmatis的统计学意义(P <0.05)。结论:从本研究中可以得出结论,PNA可能是分枝杆菌感染的潜在治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号